CRP and COVID-19: At early post-acute COVID-19 follow-up, a substantial portion of study participants presented with low-grade thrombo-inflammation, as reflected by increased IL6, neopterin, pro-calcitonin, C-reactive protein (CRP) or d-dimer blood concentrations (Table 3).